Product Program year 2022 Source: CMS Open Payments

FACSLyric

Device Cell Analysis

PDI 00382906635181

Open in the dashboard

General payments

$1,899

10 payments

Research payments

$246,977

6 payments

Through program year 2022, $1,899 in general payments and $246,977 in research payments were reported against FACSLyric (Cell Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $1,899 10
2022 Research $198,151 5
2021 Research $48,826 1

Breakdown

Who paid General payments · program year 2022
  1. Becton, Dickinson and Company $1,899 10 payments
Top recipients General payments · program year 2022
  1. Giovanni Insuasti-Beltran Anatomic Pathology & Clinical Pathology · Little Rock, AR $1,456 77% · 6 payments
  2. Eric Hsi Anatomic Pathology · Rochester, MN $443 23% · 4 payments

Each share is of general payments naming this product in 2022.

Specialties paid General payments · program year 2022
  1. Anatomic Pathology & Clinical Pathology Pathology $1,456 77% · 1 practitioner
  2. Anatomic Pathology Pathology $443 23% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Arkansas $1,456 77% · 1 recipient
  2. Ohio $443 23% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

10 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record